67,038
Views
11
CrossRef citations to date
0
Altmetric
Clinical Research

Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl

ORCID Icon, , , , , & show all
Pages 694-701 | Received 27 Nov 2021, Accepted 17 Jan 2022, Published online: 04 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kelly E. Dunn. (2023) Iteration is not solving the opioid crisis, it’s time for transformation. The American Journal of Drug and Alcohol Abuse 49:2, pages 151-158.
Read now

Articles from other publishers (10)

Whitney Bremer, Karma Plaisance, Drew Walker, Matthew Bonn, Jennifer S. Love, Jeanmarie Perrone & Abeed Sarker. (2023) Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature. Frontiers in Public Health 11.
Crossref
Deepa R. Camenga & Peter Barelli. (2023) It Is Time for Pediatric Hospitalists to Treat Opioid Use Disorder. Hospital Pediatrics 13:2, pages e34-e36.
Crossref
Anthony Spadaro, Sophia Faude, Jeanmarie Perrone, Ashish P. Thakrar, Margaret Lowenstein, M. Kit Delgado & Austin S. Kilaru. (2023) Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series. Journal of the American College of Emergency Physicians Open 4:1.
Crossref
Ashish P. Thakrar, Sophia Faude, Jeanmarie Perrone, Michael C. Milone, Margaret Lowenstein, Christopher K. Snider, Anthony Spadaro, M. Kit Delgado, Lewis S. Nelson & Austin S. Kilaru. (2023) Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Dale Terasaki & Jennifer Brady. (2023) Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. Journal of Addiction Medicine 17:1, pages 111-113.
Crossref
Neil B. Varshneya, Ashish P. Thakrar, Eugene Lambert & Andrew S. Huhn. (2023) Opioid Use Disorder Treatment in the Fentanyl Era. Journal of Addiction Medicine 17:1, pages 118-119.
Crossref
Mark K. Greenwald, Andrew A. Herring, Jeanmarie Perrone, Lewis S. Nelson & Pouya Azar. (2022) A Neuropharmacological Model to Explain Buprenorphine Induction Challenges. Annals of Emergency Medicine 80:6, pages 509-524.
Crossref
E. Andrew Townsend, Bruce E. Blough, David H. Epstein, S. Stevens Negus, Yavin Shaham & Matthew L. Banks. (2022) Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats. Neuropsychopharmacology 47:12, pages 2132-2139.
Crossref
Adams K. K.Miech E. J.Sobieraj D. M.. (2022) Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis. Addiction Science & Clinical Practice 17:1.
Crossref
Gian-Gabriel P. Garcia, Ramin Dehghanpoor, Erin J. Stringfellow, Marichi Gupta, Jillian Rochelle, Elizabeth Mason, Toyya A. Pujol & Mohammad S. Jalali. (2022) Identifying and Characterizing Medical Advice-Seekers on a Social Media Forum for Buprenorphine Use. International Journal of Environmental Research and Public Health 19:10, pages 6281.
Crossref